NanoSphere Health Sciences Inc. (CSE:NSHS, OTC:NSHSF) cannabis product brand Evolve Formulas is now stocked in over 100 dispensaries throughout Colorado. The company’s pioneering product, Transdermal NanoSerum(TM), uses the NanoSphere Delivery System(TM) developed by the biotechnology firm to allow cannabis to enter systemic circulation within ten minutes for fast-acting, effective relief from pain, inflammation and anxiety. This milestone comes on the back of continuous growth, with the company recently signing a licensing agreement in California.
“Evolve Formulas, using revolutionary nanotechnology developed by NanoSphere Health Sciences, is advancing the cannabis industry,” said David Sutton, COO and President of Nanosphere Health Sciences. “Evolve Formulas products are now available in over 100 dispensaries throughout Colorado and will soon launch in California. NanoSphere Health Sciences will continue to expand and bring these products into new markets and is currently in negotiations with several potential partners nationally and internationally.”
The patent-pending NanoSphere Delivery System(TM) is the only nanotechnology being applied to the cannabis industry that can transport THC directly into the bloodstream and to the CB1 and CB2 receptors of the endocannabinoid system. The delivery system offers precise, measurable doses and rapid absorption. Using this industry-first technology, cannabinoid molecules in NanoSerum(TM) are encapsulated in nano-sized lipid membranes, enabling them to pass through the skin into the bloodstream and cells, increasing bioavailability and bioactivity.
NanoSerum(TM) is now available in 5ml and 10ml pen sizes in select medical and recreational dispensaries. For a full list of store locations or more information, please visit https://www.evolveformulas.com/store-locator/ . The NanoSerum(TM) formula is 100 percent natural and 100 percent free of contaminants, made from natural biocompatible, biodegradable non-toxic materials.
For more information or to schedule an interview, please contact Emily Kielthy at firstname.lastname@example.org or 646-695-7045.
NanoSphere Health Sciences LLC, is a biotechnology firm specializing in the creation of the NanoSphere Delivery System(TM), a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. NanoSphere Delivery System(TM) represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years. For more information on NanoSphere, please visit http://www.nanospherehealth.com.
About Evolve Formulas
Evolve Formulas is the provider of the world’s first and only scientifically proven nanoparticle delivery system in cannabis. Evolve’s pioneering product, Transdermal NanoSerum(TM), is a fast-acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts. NanoSerum(TM) immediately penetrates the skin to deliver direct-focused results and intelligently carries a full spectrum of cannabinoids and phytochemicals to receptors throughout the body for systemic healing. Evolve Formula products leverage NanoSphere Health Sciences(TM) patent-pending NanoSphere Delivery System(TM). The NanoSphere Delivery System(TM) is a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. For more information on Evolve Formulas, visit https://www.evolveformulas.com/. Follow us on Facebook, Instagram and Twitter.
# # #
On behalf of the Board
David Sutton, President and COO
Kate Wells, Chief Marketing Officer
NanoSphere Health Sciences, LLC
Victor Goncalves, Executive Vice President
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statement Caution
This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company’s intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company’s future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.